Pharmaceutical manufacturing

FILE - In this June 15, 2018, file photo, pharmaceuticals are seen in North Andover, Mass. Feeling a new urgency as the impeachment probe advances, the White House is ramping up its push to get a bill through Congress that curbs prescription drug costs. President Donald Trump’s top domestic policy adviser says the effort has advanced beyond anything seen in years even as he acknowledges the “current complications.” (AP Photo/Elise Amendola, file)
November 17, 2019 - 7:55 am
WASHINGTON (AP) — The White House is ramping up its push to get a bill through Congress that curbs prescription drug costs, feeling a new urgency as the impeachment investigation advances amid the 2020 election campaign. The effort has progressed beyond anything seen in years, says President Donald...
Read More
FILE - This undated photo provided by Amarin in November 2018 shows a capsule of the purified, prescription fish oil Vascepa. On Thursday, Nov. 14, 2019, government health advisers recommended broader use of the prescription-strength fish oil drug to prevent heart attack, stroke and other life-threatening health problems. (Amarin via AP)
November 14, 2019 - 6:17 pm
WASHINGTON (AP) — Government health experts on Thursday recommended broader use of a prescription-strength fish oil drug to help many more patients at risk for heart attack, stroke and related health problems. Currently the drug, Vascepa, is approved for a relatively narrow group of patients with...
Read More
House Speaker Nancy Pelosi of Calif., speaks during a news conference on Capitol Hill in Washington, Thursday, Oct. 31, 2019. (AP Photo/Susan Walsh)
November 05, 2019 - 1:13 pm
WASHINGTON (AP) — The White House has concluded that House Speaker Nancy Pelosi's plan authorizing Medicare to negotiate drug prices is "unworkable" and President Donald Trump will instead support bipartisan legislation in the Senate, a senior White House official said Tuesday. Despite the House...
Read More
House Speaker Nancy Pelosi of Calif., speaks during a news conference on Capitol Hill in Washington, Thursday, Oct. 31, 2019. (AP Photo/Susan Walsh)
November 05, 2019 - 12:27 pm
WASHINGTON (AP) — The White House says House Speaker Nancy Pelosi's plan authorizing Medicare to negotiate prescription drug prices is "unworkable" and President Donald Trump is instead supporting bipartisan Senate legislation. A senior White House official tells The Associated Press the...
Read More
Edward McCarthy, center, works with fellow traders on the floor of the New York Stock Exchange, Tuesday, Oct. 29, 2019. Stocks are off to a slightly lower start on Wall Street as communications and energy companies fall. (AP Photo/Richard Drew)
October 29, 2019 - 5:53 pm
Technology companies led stocks lower on Wall Street Tuesday as a wobbly day of trading ended with modest losses for the market. Health care stocks jumped on stronger-than-expected reports from drugmakers, but losses by internet and media companies held the market in check. Companies have largely...
Read More
Edward McCarthy, center, works with fellow traders on the floor of the New York Stock Exchange, Tuesday, Oct. 29, 2019. Stocks are off to a slightly lower start on Wall Street as communications and energy companies fall. (AP Photo/Richard Drew)
October 29, 2019 - 4:56 pm
Technology companies led stocks lower on Wall Street Tuesday as a wobbly day of trading ended with modest losses for the market. Health care stocks jumped on stronger-than-expected reports from drugmakers, but losses by internet and media companies held the market in check following a mixed report...
Read More
Edward McCarthy, center, works with fellow traders on the floor of the New York Stock Exchange, Tuesday, Oct. 29, 2019. Stocks are off to a slightly lower start on Wall Street as communications and energy companies fall. (AP Photo/Richard Drew)
October 29, 2019 - 3:09 pm
Major U.S. stock indexes veered slightly lower in afternoon trading Tuesday as investors weighed a mixed set of earnings reports from big companies. The S&P 500 was essentially flat after spending much of the day drifting between small gains and losses a day after climbing to an all-time high...
Read More
Edward McCarthy, center, works with fellow traders on the floor of the New York Stock Exchange, Tuesday, Oct. 29, 2019. Stocks are off to a slightly lower start on Wall Street as communications and energy companies fall. (AP Photo/Richard Drew)
October 29, 2019 - 12:22 pm
NEW YORK (AP) — U.S. stocks drifted around their record highs Tuesday, and the S&P 500 slinked between small gains and losses following a mixed set of earnings reports from big companies. Health care stocks jumped on stronger-than-expected reports from drugmakers, but losses for internet and...
Read More
FILE - In this April 26, 2019, file photo, RELPAX migraine pills manufactured by Pfizer are arranged for a photo in Doral, Fla. Pfizer Inc. reports financial earns Tuesday, Oct. 29. (AP Photo/Wilfredo Lee, File)
October 29, 2019 - 8:07 am
Pfizer's third-quarter profit nearly doubled after it booked a $8.1 billion gain on the creation of a consumer health products joint venture, part the drugmaker's plan to narrow its focus on cancer treatments and other innovative medicines. The New York company's profit handily beat Wall Street...
Read More
FILE- This May 1, 2018, file photo shows Merck corporate headquarters in Kenilworth, N.J. Merck & Co. reports financial earns Tuesday, Oct. 29, 2019. (AP Photo/Seth Wenig, File)
October 29, 2019 - 7:47 am
Big jumps in sales of Merck's top two blockbuster drugs drove revenue up 15%, but higher spending across the board pushed profits down 3% in the third quarter. Merck still easily beat Wall Street forecasts and boosted its forecast for the year. The quarter were dominated again by advanced cancer...
Read More

Pages